Site-specific drug delivery in the skin for the localized treatment of skin diseases
- PMID: 31311345
- DOI: 10.1080/17425247.2019.1645119
Site-specific drug delivery in the skin for the localized treatment of skin diseases
Abstract
Introduction: Due to the well-organized structure and barrier function of the skin, it is generally difficult for drugs applied directly on the surface of skin to reach their expected site of action. Accordingly, site-specific drug delivery in the skin has been increasingly explored to facilitate the treatment of skin diseases and reduce the systemic toxicity. Area covered: An overview of the generally used sites for drug delivery in the skin is herein presented. Different strategies including particle-based carriers, physical technologies, and chemical approaches are discussed with regards to their potential application in site-specific drug delivery in the skin. Expert opinion: Particle-based carriers are of particular significance for the enhancement of drug delivery in the skin. Although no recommendation can be made regarding which type of carriers can provide better skin penetration, the lipid-based colloidal systems appear to be favored due to their compatibility. In addition, the physical technologies provide unique advantages in delivering hydrophilic macromolecules for the skin immunization. As a new class of permeation enhancers, skin penetrating peptides are gaining more attention in drug delivery to skin cells. For the design of robust site-specific drug delivery systems, the impacts of diseased state and drug properties should not be disregarded.
Keywords: Site-specific; drug delivery; microneedles; nanoparticles; prodrugs; skin disease.
Similar articles
-
Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders.Expert Opin Drug Deliv. 2017 Jan;14(1):109-122. doi: 10.1080/17425247.2016.1206073. Epub 2016 Jul 7. Expert Opin Drug Deliv. 2017. PMID: 27348356 Review.
-
Nanocarrier-based topical drug delivery for the treatment of skin diseases.Expert Opin Drug Deliv. 2012 Jul;9(7):783-804. doi: 10.1517/17425247.2012.686490. Epub 2012 May 5. Expert Opin Drug Deliv. 2012. PMID: 22559240 Review.
-
[Skin permeation and transdermal delivery systems of drugs: history to overcome barrier function in the stratum corneum].Yakugaku Zasshi. 2009 Dec;129(12):1453-8. doi: 10.1248/yakushi.129.1453. Yakugaku Zasshi. 2009. PMID: 19952520 Review. Japanese.
-
Advances in lyotropic liquid crystal systems for skin drug delivery.Expert Opin Drug Deliv. 2020 Dec;17(12):1781-1805. doi: 10.1080/17425247.2020.1819979. Epub 2020 Sep 18. Expert Opin Drug Deliv. 2020. PMID: 32886531 Review.
-
Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.Int J Pharm. 2018 Jan 15;535(1-2):1-17. doi: 10.1016/j.ijpharm.2017.10.046. Epub 2017 Oct 27. Int J Pharm. 2018. PMID: 29111097 Review.
Cited by
-
A Review of 3D-Printing of Microneedles.Pharmaceutics. 2022 Dec 1;14(12):2693. doi: 10.3390/pharmaceutics14122693. Pharmaceutics. 2022. PMID: 36559187 Free PMC article. Review.
-
Enhanced Topical Delivery of Methotrexate via Transferosome-Loaded Microneedle Array Patch: Formulation, Optimization, and In Vitro-In Vivo Assessment.Pharmaceuticals (Basel). 2025 Apr 18;18(4):594. doi: 10.3390/ph18040594. Pharmaceuticals (Basel). 2025. PMID: 40284029 Free PMC article.
-
Probing Pharmaceutical Strategies to Promote the Skin Delivery of Asiatic Acid from Hydrogels: Enhancement Effects of Organic Amine Counterions, Chemical Enhancers, and Microneedle Pretreatment.Pharmaceutics. 2022 Nov 20;14(11):2532. doi: 10.3390/pharmaceutics14112532. Pharmaceutics. 2022. PMID: 36432722 Free PMC article.
-
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.Transplant Cell Ther. 2021 Oct;27(10):817-835. doi: 10.1016/j.jtct.2021.06.001. Epub 2021 Jun 10. Transplant Cell Ther. 2021. PMID: 34217703 Free PMC article.
-
Topical calcineurin and mammalian target of rapamycin inhibitors in inflammatory dermatoses: Current challenges and nanotechnology‑based prospects (Review).Int J Mol Med. 2024 Oct;54(4):85. doi: 10.3892/ijmm.2024.5409. Epub 2024 Aug 12. Int J Mol Med. 2024. PMID: 39129316 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials